Amantadine, oseltamivir and zanamivir for the treatment of influenza.

GUIDELINE TITLE
Amantadine, oseltamivir and zanamivir for the treatment of influenza.

BIBLIOGRAPHIC SOURCE(S)
National Institute for Health and Clinical Excellence (NICE). Amantadine, oseltamivir and zanamivir for the treatment of influenza. London (UK): National Institute for Health and Clinical Excellence (NICE); 2009 Feb. 40 p. (Technology appraisal guidance; no. 168).

GUIDELINE STATUS
This is the current release of the guideline.

This guideline updates a previous version: National Institute for Clinical Excellence (NICE). Guidance on the use of zanamivir, oseltamivir and amantadine for the treatment of influenza. London (UK): National Institute for Clinical Excellence (NICE); 2003 Feb. 30 p. (Technology appraisal guidance; no. 58).

The review date for this guideline is November 2013.

abrir aquí para acceder al documento NGC AHRQ completo:
Amantadine, oseltamivir and zanamivir for the treatment of influenza.